March 31, 2020
Rose
The Washington Post takes a look at Johnson & Johnson's operations in Tasmania, which produced genetically modified "supper poppy" plants. In other public health news: e-cigarettes, mental health services, Alzheimer's treatments, and dementia.
from Kaiser Health News https://ift.tt/2WX7IzX
March 31, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Fresh Faces, Fewer Tools: Meet the New Bosses Fighting Covid- Direct Primary Care, With a Touch of Robin Hood
- Understaffed State Psychiatric Facilities Leave Mental Health Patients in Limbo
- Analysis: A Procedure That Cost $1,775 in New York Was $350 in Maryland. Here’s Why.
- 3 States Limit Nursing Home Profits in Bid to Improve Care
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment